Source: EU Commission
The European Commission has approved, under the EU Merger Regulation, the acquisition of joint control over WELL Gesundheit AG (‘WELL’) by CSS Holding AG (‘CSS’), belonging to CSS Group, Visana Beteiligungen AG (‘Visana’), belonging to Visana Group, Zur Rose Group AG (‘Zur Rose’), belonging to Zur Rose Group and medi24 AG (‘medi24′), belonging to Allianz SE, all of Switzerland. WELL will be active in the development and operation of a digital health platform for the Swiss market. CSS and its subsidiaries provide health care insurance, accident insurance and supplementary and non-life insurance in Switzerland. Visana and its subsidiaries offer compulsory health care insurance, supplementary and non-life insurance and accident insurance in Switzerland. Zur Rose is active in mail-order pharmacies and as a marketplace for customary health and care products. medi24 is a telemedicine centre of expertise with the status of a Swiss medical office. The Commission concluded that the proposed acquisition would raise no competition concerns, because of its limited impact in the European Economic Area. The transaction was examined under the simplified merger review procedure. More information is available on the Commission’s competition website, in the public case register under the case number M.10197.